122702-20-9

Usage

Uses

Used in Scientific Research:
D-serine hydrochloride is used as a research tool for studying the role of D-serine in neurotransmission and synaptic plasticity, aiding in the understanding of its involvement in neurological conditions.
Used in Pharmaceutical Preparations:
D-serine hydrochloride is used as an active ingredient in the preparation of experimental solutions, serving as a reference standard for analytical testing in the development of pharmaceuticals targeting neurological disorders.
Used in Neurotransmission Studies:
In the field of neuroscience, D-serine hydrochloride is used as a research compound to explore its potential role in conditions such as schizophrenia and Alzheimer's disease, providing insights into the mechanisms of these diseases and contributing to the development of therapeutic strategies.
Safety and Storage:
It is crucial to handle D-serine hydrochloride with care due to its potential harmful effects if ingested or inhaled. It should be stored in a cool, dry place, away from heat and light, to maintain its stability and effectiveness for research and pharmaceutical applications.

Upstream product

• 80312-69-2 tert-butyl (R)-(1-amino-3-hydroxy-1-oxopropan-2-yl)carbamate 

Downstream Products

• 116833-21-7 (R)-2-dimethylamino-3-hydroxypropionamide 
• 556-02-5 ?Tyr 
• 1436422-13-7 (R)-4-((1-amino-3-hydroxy-1-oxopropan-2-ylamino)methyl)-N-(4-chloro-2-(4-(3,3,3-trifluoropropyl)piperazin-1-yl)phenyl)-2,3-difluorobenzamide 
• 1436421-67-8 (R)-4-((1-amino-3-hydroxy-1-oxopropan-2-ylamino)methyl)-N-(4-chloro-2-(4-(3,3,3-trifluoropropyl)piperazin-1-yl)phenyl)-2-fluorobenzamide hydrochloride 

Relevant academic research and scientific papers

MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof that are useful in methods of treatment and alleviation of diseases and disorders of the heart, brain, kidney, immune, and reproductive system resulting from ischemia, or reperfusion subsequent to ischemia, and any downstream complication(s) related thereto. The present invention further relates to methods of treatment and alleviation of diseases and disorders of the vasculature resulting from vasoconstriction or hypertension and any downstream complication(s) resulting from elevated blood pressure and/or reduced tissue perfusion.

AZAARENE DERIVATIVES

A compound represented by the general formula: wherein X1 represents a nitrogen atom or a group represented by the formula -CR10=; X2 represents a nitrogen atom or a group represented by the formula -CR11=; Y represents an oxygen atom or the like; R1 represents a C1-6 alkoxy group, an optionally substituted C6-10 aryloxy group, a group represented by the formula -NR12aR12b or the like; R2 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like; R3, R4, R5, R6, R7, R8, R10 and R11 each independently represent a hydrogen atom, a halogen atom, an optionally substituted C1-6 alkyl group, or the like; R9 represents a group represented by the formula -NR16aR16b or the like; and R12a, R12b, R16a and R16b each independently represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, a salt thereof, or a hydrate of the foregoing.